Literature DB >> 8191285

Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors.

A Novogrodsky1, A Vanichkin, M Patya, A Gazit, N Osherov, A Levitzki.   

Abstract

Septic shock results from excessive stimulation of the host immune system, especially macrophages, by lipopolysaccharide (LPS), or endotoxin, which resides on the outer membrane of bacteria. Protein tyrosine kinase inhibitors of the tyrphostin AG 126 family protect mice against LPS-induced lethal toxicity. The protection correlates with the ability of these agents to block LPS-induced production of tumor necrosis factor alpha (TNF-alpha) and nitric oxide in macrophages as well as LPS-induced production of TNF-alpha in vivo. Furthermore, this inhibitory effect correlated with the potency of AG 126 to block LPS-induced tyrosine phosphorylation of a p42MAPK protein substrate in the murine macrophage.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8191285     DOI: 10.1126/science.8191285

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  65 in total

1.  The tyrosine kinase inhibitor tyrphostin AG126 reduces the development of acute and chronic inflammation.

Authors:  S Cuzzocrea; M C McDonald; E Mazzon; D Siriwardena; G Calabrò; D Britti; G Mazzullo; A De Sarro; A P Caputi; C Thiemermann
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

Review 2.  A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases.

Authors:  Nishkantha Arulkumaran; Robert J Unwin; Frederick Wk Tam
Journal:  Expert Opin Investig Drugs       Date:  2011-04-21       Impact factor: 6.206

3.  Lipopolysaccharide-binding protein- and CD14-dependent activation of mitogen-activated protein kinase p38 by lipopolysaccharide in human neutrophils is associated with priming of respiratory burst.

Authors:  Sen Rong Yan; Walla Al-Hertani; David Byers; Robert Bortolussi
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

Review 4.  Targeting non-malignant disorders with tyrosine kinase inhibitors.

Authors:  Friedrich Grimminger; Ralph T Schermuly; Hossein A Ghofrani
Journal:  Nat Rev Drug Discov       Date:  2010-12       Impact factor: 84.694

5.  Compound 9a, a novel synthetic histone deacetylase inhibitor, protects against septic injury in mice by suppressing MAPK signalling.

Authors:  So-Jin Kim; Ki Seon Baek; Hyun-Ju Park; Young Hoon Jung; Sun-Mee Lee
Journal:  Br J Pharmacol       Date:  2016-02-22       Impact factor: 8.739

6.  Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-alpha) translation: glucocorticoids inhibit TNF-alpha translation by blocking JNK/SAPK.

Authors:  J L Swantek; M H Cobb; T D Geppert
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

7.  Pentoxifylline pretreatment fails to block the acute-phase response to Escherichia coli endotoxin in dwarf goats.

Authors:  C T Van Duin; T Wensing; A S Van Miert
Journal:  Vet Res Commun       Date:  1995       Impact factor: 2.459

8.  Induction of macrophage procoagulant activity by murine hepatitis virus strain 3: role of tyrosine phosphorylation.

Authors:  A P Dackiw; K Zakrzewski; A B Nathens; P Y Cheung; R Fingerote; G A Levy; O D Rotstein
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

9.  Endogenously opsonized particles divert prostanoid action from lethal to protective in models of experimental endotoxemia.

Authors:  D F Eierman; M Yagami; S M Erme; S R Minchey; P A Harmon; K J Pratt; A S Janoff
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

10.  Tumour necrosis factor-alpha-induced ICAM-1 expression in human vascular endothelial and lung epithelial cells: modulation by tyrosine kinase inhibitors.

Authors:  A Burke-Gaffney; P G Hellewell
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.